Somalogic stock.
Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …
With Somalogic stock trading at $2.83 per share, the total value of Somalogic stock (market capitalization) is $532.24M. Somalogic stock was originally listed at a price of …View SomaLogic, Inc SLGC investment & stock information. Get the latest SomaLogic, Inc SLGC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.SomaLogic Inc.’s SLGC, +10.78% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to …UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...
SomaLogic last released its earnings results on November 8th, 2023. The reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.05. The firm had revenue of $22.05 million for the quarter, compared to analysts' expectations of $20.45 million. SomaLogic has generated ($0.69) earnings per share over the last year ...
Headline. SomaLogic Inc Class A. morningstar.com - November 22 at 6:40 PM. With 54% ownership of the shares, SomaLogic, Inc. (NASDAQ:SLGC) is heavily dominated by institutional owners. finance.yahoo.com - November 22 at 1:39 PM. SomaLogic, Inc. (NASDAQ:SLGC) Q3 2023 Earnings Call Transcript. finance.yahoo.com - November 12 at 9:33 AM.SomaLogic, Inc. Stock Prediction 2025. The SomaLogic, Inc. stock prediction for 2025 is currently $ 1.372003, assuming that SomaLogic, Inc. shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -51.35% increase in the SLGC stock price. SomaLogic, Inc. Stock Prediction 2030
Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...Nov 18, 2023 · SomaLogic, Inc. (NASDAQ:SLGCW – Get Free Report)’s stock price rose 6.3% on Wednesday . The company traded as high as $0.17 and last traded at $0.17. Approximately 72,147 shares were traded during trading, an increase of 1,225% from the average daily volume of 5,446 shares. The stock had previously closed at $0.16. SomaLogic Stock Performance […] SomaLogic (NASDAQ:SLGCW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership, community ranking and risk.SomaLogic will host a conference call at 4:30 p.m. ET on Thursday, May 12, 2022, to discuss its first quarter 2022 financial results. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding at March 31, ...
Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ...
Commercial Services. Industry. Miscellaneous Commercial Services. No executives to display. Corporate headquarters. --, --. Find real-time SLGC - Somalogic Inc stock quotes, company profile, news ...
SomaLogic and Standard BioTools announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 billion.SomaLogic common stock is traded on the Nasdaq exchange under the symbol SLGC, and SomaLogic warrants are traded on the Nasdaq under the symbol SLGCW. Does SomaLogic pay dividends? SomaLogic does not expect to declare or pay any cash or other dividends on its common stock.Nov 22, 2023 · Public companies currently own 5.5% of SomaLogic stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …
SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate ...SomaLogic is a community of people with diverse expertise but a singular purpose — to foster the discovery of new, effective and safer treatments for patients while empowering more accurate diagnosis, prevention and treatment of disease through the next generation of proteomics. Our team of world-class scientists, directors and administrators ...SomaLogic, Inc. (SLGCW) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 0.1500 0.0000 (0.00%) At close: 10:20AM EST 1d 5d 1m 6m YTD 1y 5y Max Full screen Trade prices are not sourced... Oct 4, 2023 · SomaLogic shareholders will receive 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock owned. Upon the close of the deal, Standard BioTools shareholders will ... According to 4 stock analysts, the average 12-month stock price forecast for SomaLogic stock is $4.70, which predicts an increase of 66.67%. The lowest target is $2.30 and the highest is $7.00. On average, analysts rate SomaLogic stock as a buy.
If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.
SomaLogic and Standard BioTools announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 billion.Stock analysis for SomaLogic Inc (CMII:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.SomaLogic is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado. It became listed on Nasdaq in September 2021 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. [2]In the process, SomaLogic will receive up to $651 million in cash from CMLS II’s IPO earnings and common stock purchases from a handful of investors, bringing its total amount of cash available ...SomaLogic Inc.’s SLGC, +10.78% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to …UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...SomaLogic, Inc. (SLGCW) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 0.1500 0.0000 (0.00%) At close: 10:20AM EST 1d 5d 1m 6m YTD 1y 5y Max Full screen Trade prices are not sourced...
Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.
View the latest SomaLogic Inc. (SLGC) stock price, news, historical charts, analyst ratings and financial information from WSJ.
SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their …SomaLogic will host a conference call at 4:30 p.m. ET on Thursday, May 12, 2022, to discuss its first quarter 2022 financial results. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding at March 31, ...Sep 1, 2021 · Following the transaction, the combined company was renamed SomaLogic, Inc., and its Class A common stock and warrants will begin trading on the Nasdaq Global Market (“Nasdaq”) on September 2, 2021 under the symbols “SLGC” and “SLGCW,” respectively. SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ...Stockholder, Stake, Shares owned, Total value ($), Shares bought / sold, Total change. ARK Investment Management LLC, 6.88%, 12,983,002, 28,952,094 ...SomaLogic will host a conference call at 4:30 p.m. ET on Thursday, May 12, 2022, to discuss its first quarter 2022 financial results. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding at March 31, ...SomaLogic is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado. It became listed on Nasdaq in September 2021 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. [2] Under the terms of the merger agreement, SomaLogic will pay at closing $35 million, comprising $14 million in cash and $21 million in SomaLogic common stock. Up to an additional $17.5 million may be paid in connection with the achievement of certain future revenue-based milestones.Healthcare company SomaLogic, Inc. (SLGC) operates as a protein biomarker discovery and clinical diagnostics firm, developing slow off-rate modified aptamers (SOMAmers) and offering proprietary SomaScan services.Renowned investor Cathie Wood’s firm ARK Invest owns 11.02 million SLGC shares for a total value of $31.95 …Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by ...Mar 28, 2023 · SomaLogic, Inc. (SLGC) delivered earnings and revenue surprises of 0% and 21.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? Nov 17, 2023 · According to the issued ratings of 5 analysts in the last year, the consensus rating for SomaLogic stock is Hold based on the current 3 hold ratings and 2 buy ratings for SLGC. The average twelve-month price prediction for SomaLogic is $4.26 with a high price target of $7.00 and a low price target of $2.30. Learn more on SLGC's analyst rating ...
Stock analysis for SomaLogic Inc (CMII:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Standard BioTools ( NASDAQ: LAB) said it will combine in an all stock merger with SomaLogic ( NASDAQ: SLGC) The combined company will have a pro forma equity value of over $1B as per LAB's closing ...Why SomaLogic Stock Dived by 10% on Wednesday The market wasn't impressed by the company's announced tie-up with Standard BioTools. Eric Volkman | Oct 4, 2023Instagram:https://instagram. tecl holdingsfisker teslacoinrulesis coverwallet insurance legit Research SomaLogic's (Nasdaq:SLGC) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Research SomaLogic's (Nasdaq:SLGC) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard … ttwo sharehymtf SomaLogic Reports Second Quarter 2022 Financial Results. August 15, 2022 at 4:05 PM EDT. PDF Version. Second quarter 2022 revenue of $14.1 million, bringing year to date revenue to $37.1 million. Reducing 2022 revenue guidance to $80-90 million to account for ongoing variability in core service business, macroeconomic and commercial factors.Revenue for the 3 months ended September 30, 2023, was $22 million as compared to $41.7 million in the third quarter of 2022, a 47% year-over-year decline on a GAAP basis. Excluding $22.3 million ... cv3 financial services Get the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing. See the performance …Information concerning SomaLogic’s directors and executive officers, including their ownership of SomaLogic securities, is set forth in the joint proxy statement/prospectus, SomaLogic’s proxy ...Somalogic stock was originally listed at a price of $12.49 in Feb 23, 2021. If you had invested in Somalogic stock at $12.49, your return over the last 2 years would have been -81.91%, for an annualized return of -57.46% (not including any dividends or dividend reinvestments).